Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Accent Therapeutics discloses METTL3 inhibitors

May 11, 2022

Proxygen and collaborators present new compounds for cancer

May 11, 2022

TL-532 induces life-long antitumor autovaccination and cross-immunity against unrelated cancers

May 11, 2022

SIGLEC15 promotes immune system evasion in lymphoma

May 11, 2022

Discovery of potent and orally bioavailable CSNK1A1 inhibitors

May 10, 2022

Shanghai De Novo Pharmatech synthesizes new ATR kinase inhibitors

May 10, 2022

Beijing Jacobio Pharmaceuticals identifies new glutaminase inhibitors

May 10, 2022

Ranok Therapeutics presents new CHAMPs for cancer

May 10, 2022

Universite du Luxembourg discloses new PDE6D inhibitors

May 10, 2022

Celgene ERK/NLK inhibitor CC-91516 shows activity against BRAF and CTNNB1 mutant tumors

May 9, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...